Obtenez 3 mois à 0,99 $/mois

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Rx for Biotech

Rx for Biotech

Rx for Biotech

Auteur(s): Podcast Host Chris Leidli
Écouter gratuitement

À propos de cet audio

 The Rx for Biotech podcast is focused on the promise of advanced therapies and the leaders across the healthcare ecosystem bringing these innovative medicines to patients in need. The podcast features interviews with the experts who are developing advanced therapies and AI-powered health technologies including physicians, healthcare providers, patient advocates, and technology leaders. To learn more about Advanced Therapies, visit our Knowledge Base: https://www.advancedtherapiesconnect.ai/knowledge-base To find a specialist at an advanced therapy treatment center, visit our Advanced Therapy AI-powered referral tool here: https://www.advancedtherapiesconnect.ai/ To learn more about Genoplex, please visit https://www.genoplex.aiAll rights reserved Économie
Épisodes
  • Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control

    Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control
    Nov 20 2025
    InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and autoimmune disease. We break down the science behind INF904, and why C5a is such a powerful immune driver, and how precision immunology is shaping the next wave of treatment innovation.
    Voir plus Voir moins
    35 min
  • How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases

    How Novel Genetic Medicines may improve treatment of chronic Neurological Diseases
    Nov 11 2025
    In this episode of Rx for Biotech podcast, I speak with Philippe Chambon MD, PhD, CEO of EG 427, about how his company's HERMES technology platform could improve on the precision, durability and safety of gene therapy delivery. EG 427's lead candidate, EG110A, targets neurogenic bladder - a chronic condition linked to spinal cord injury, Parkinson's disease and multiple sclerosis - using a localized gene therapy designed to restore neuronal control with minimal side effects.
    Voir plus Voir moins
    29 min
  • Restoring Breath: Biologic Innovation for the Most Vulenerable Patients

    Restoring Breath: Biologic Innovation for the Most Vulenerable Patients
    Oct 28 2025
    Airway Therapeutics is taking on one of the toughest challenges in medicine - helping premature infants breathe on their own. In this episode of Rx for Biotech, CEO Marc Salzberg shares how zelpultide alfa, an investigational, first-in-class biologic, could transform care for newborns with bronchopulmonary dysplasia (BPD) and unlock a new future for respiratory medicine.
    Voir plus Voir moins
    21 min
Pas encore de commentaire